National, Prospective, Observational, Cohort Study of Venous Thromboembolism (VTE) Management With the Low Molecular Weight Heparin, Enoxaparin, in the Outpatient Setting in Canada.
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2010
At a glance
- Drugs Enoxaparin sodium; Low molecular weight heparins
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Acronyms RECOVERY
- Sponsors Sanofi
- 30 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2010 New trial record